Investing in health of people and planet
This World Health Day engaging with companies on pollution and biodiversity, as well as human health concerns, will help build a fairer world
Healthcare
-
-
Asset managers call for ‘fair and equitable’ global efforts to end pandemic
‘We will not end the pandemic anywhere until we end it everywhere’, says WHO director-general as he welcomes investor initiative
-
Update: FCA considers ‘fitness of management’ in Woodford return
Regulator issues statement as governance questions surround Woodford’s proposed new Jersey fund
-
Global equity outlook: Managers point to ESG bubble, healthcare and ‘future-fit leaders’ as top priorities for 2021
ESG investment managers share how the vaccine rollout and the race to net zero will impact global equity markets
-
Five ESG themes for 2021 and funds to capture them
CGWM’s Patrick Thomas says ESG investing attracts some very talented fund managers
-
Mental health benchmark built to remove workplace stigma
CCLA has launched the Mental Health Benchmark focusing initially on FTSE 100 companies
-
Rathbones calls for greater incentives to combat rising antibiotic resistance
Investment in antibiotics has slowed to a historically low rate, according to the first Planet Papers from Rathbones
-
Insurance companies discriminate against some clients
Insurance companies offering life and/or critical illness cover refusing some applications
-
Insurance companies discriminate against some clients
Insurance companies offering life and/or critical illness cover refusing some applications
-
ESG fund managers reveal changes made in coronavirus sell-off – part 2
In this second instalment, ESG Clarity finds out fund managers’ key asset allocation calls throughout coronavirus volatility
-
ESG fund managers reveal changes made in coronavirus sell-off – part 2
In this second instalment, ESG Clarity finds out fund managers’ key asset allocation calls throughout coronavirus volatility
-
Covid-19 highlights role of urbanisation and climate change in public health crises
Invesco’s Glen Yelton analyses how infectious diseases are proliferating and, moreover, how environmental changes and human actions are exacerbating these problems